Natascha Dixon Edelin

Natascha Dixon Edelin partners with clients to navigate dynamic market changes, understand their strategic opportunities and implement innovative payment and delivery models.

  With over 20 years of healthcare and business consulting experience, she has a demonstrated record of tailoring solutions to meet each client’s business challenge and facilitate measurable outcomes.

Prior to joining Avalere, Natascha was an associate vice president with CareAllies. She led product development initiatives targeted at transitioning providers and independent physician associations from fee-for-service to risk- and value-based reimbursement models.  She also served as a senior director with Evolent, leading large, complex multidisciplinary teams, providing integrated value-based care solutions and transforming the way healthcare is provided to patients by partnering with health plans, integrated delivery systems, hospitals, and provider groups. As a strategic adviser, Natascha also partnered with the VA, Department of Homeland Security, Marine Corps, and IRS to develop and operationalize strategic plans, performance management systems, multitiered investment management governance boards, and a nation-wide cost-reduction and quality-improvement pilot program.

Natascha holds an MA in international economics and international relations from The Johns Hopkins University School of Advanced International Studies and a BA in political science and German studies from Wellesley College.

Authored Content

Avalere experts discussed the latest policy, reimbursement, and program changes affecting post-acute care and why they matter.

Avalere worked with a healthcare organization to assess the impact of their quality improvement program over a 4-year period. The organization prepared primary and specialty care providers/practices to transition from fee-for-service (FFS) to value-based payment arrangements. Avalere’s analysis found participation in the program led to a reduction in both emergency department (ED) visits as well as inpatient (IP) admissions over the period reviewed.